Lymphoma molluscatum.
Modschiedler
K
K
Altenhoff
J
J
von den Driesch
P
P
D003131:Combined Modality Therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D008976:Molluscum Contagiosum / Q000150:complications* / Q000276:immunology / Q000628:therapy; D009182:Mycosis Fungoides / Q000150:complications* / Q000276:immunology / Q000628:therapy; D011701:PUVA Therapy; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000150:complications* / Q000276:immunology / Q000628:therapy; D018418:Th2 Cells / Q000276:immunology
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins